This retrospective analysis of data from two multi-center, randomized, double-blind, parallel
group studies compared the efficacy of fluticasone propionate/salmeterol (FSC) 250/50mcg …

Background: This is the first comparison of two combination therapies, fluticasone
propionate/salmeterol and ipratropium bromide/albuterol (salbutamol), for the treatment of …

BACKGROUND: Chronic obstructive pulmonary disease (COPD) patients are thought to
have limited bronchodilator response, determined by changes in forced expiratory volume in …

Objective Bronchodilators are routinely used in the long-term therapy of patients with COPD.
These drugs are generally evaluated for their short-term bronchodilatory effects. Long-term …

BACKGROUND:: The pathology of chronic obstructive pulmonary disease (COPD) includes
both obstructive and inflammatory components. OBJECTIVE:: The aim of this study was to …

In the present trial, we compared the broncholytic efficacy of the combination therapy with 50
μg salmeterol+ 250 μg fluticasone and 12 μg formoterol+ 400 μg budesonide, both in a …

Background Chronic obstructive pulmonary disease (COPD) is a heterogeneous disorder
characterized by usually progressive development of airflow obstruction that is not fully …

Background Patients with chronic obstructive pulmonary disease (COPD) experience
respiratory symptoms, which impair quality of life. This pooled analysis of two Phase III …

Study objectives To determine whether the combination of ipratropium bromide and
albuterol results in greater and more consistent pulmonary function test (PFT) response …

Study objectives. The aim of this study was to compare the relative efficacy in terms of
improvement in symptoms and lung function of salmeterol/fluticasone propionate (SLM/FP) …